Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-25 Sale |
2023-05-26 7:29 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,635 | $1.4196 | $5,160 | 147,387 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 6:28 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,156 | $1.6812 | $3,625 | 85,233 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 6:22 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,599 | $1.6812 | $6,051 | 151,022 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-29 5:33 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,532 | $2.7196 | $9,606 | 154,621 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-29 5:25 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,116 | $2.7193 | $5,754 | 87,389 (Direct) |
View |
| 2022-08-26 Sale |
2022-08-29 9:18 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,190 | $4.0118 | $8,786 | 89,505 (Direct) |
View |
| 2022-08-26 Sale |
2022-08-29 9:14 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,655 | $4.0162 | $14,679 | 158,153 (Direct) |
View |
| 2022-08-26 Sale |
2022-08-29 9:11 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
13,379 | $4.0105 | $53,656 | 908,778 (Indirect Direct) |
View |
| 2022-05-26 Sale |
2022-05-27 5:34 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
13,162 | $1.9011 | $25,022 | 922,157 (Indirect Direct) |
View |
| 2022-05-26 Sale |
2022-05-27 5:32 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,154 | $1.9011 | $4,095 | 91,695 (Direct) |
View |
| 2022-05-26 Sale |
2022-05-27 5:27 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,596 | $1.9011 | $6,836 | 161,808 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-09 6:19 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Chung Jane Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:13 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 6:11 pm |
N/A 2033-06-08 |
Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-05-25 Exercise |
2023-05-26 7:32 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-05-25 Exercise |
2023-05-26 7:30 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,035 | $0 | 144,547 (Direct) |
View |
| 2023-05-25 Exercise |
2023-05-26 7:29 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 147,387 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-17 5:05 pm |
N/A 2033-03-16 |
Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-17 5:03 pm |
N/A 2033-03-16 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-17 4:57 pm |
N/A 2033-03-16 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:30 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:28 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 85,233 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:25 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:22 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 151,022 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:33 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 154,621 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:25 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 87,389 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:21 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:18 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR Director |
25,219 | $0 | 908,778 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-19 7:04 pm |
N/A 2032-09-19 |
Viracta Therapeutics Inc. | VIRX | Rothera Mark President and CEO |
1,375,000 | $0 | 1,375,000 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:18 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 89,505 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:16 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:14 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 158,153 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:11 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
25,219 | $0 | 908,778 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-11 7:01 pm |
N/A 2032-08-10 |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
30,282 | $0 | 30,282 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-11 6:58 pm |
N/A 2032-08-10 |
Viracta Therapeutics Inc. | VIRX | Chung Jane Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:16 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:13 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:10 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:07 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | ONETTO NICOLE Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:04 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:59 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Huang Michael Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:56 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:54 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:51 pm |
N/A 2032-06-09 |
Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:34 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
25,219 | $0 | 922,157 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:32 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 91,695 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:30 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:27 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 161,808 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:35 pm |
N/A 2032-03-17 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
195,000 | $0 | 195,000 (Direct) |
View |